Maryland

MD at a Glance

Launched in 2009, We Work For Health – Maryland is an effort to promote the significant social and economic value of the biopharmaceutical and life sciences sectors in our state. Our partnership includes biotechnology and pharmaceutical companies, as well as state and local chambers of commerce, academic and research institutions, labor, patient advocate groups, physicians and healthcare providers. Together, our mission is to drive innovation, research and development to new cures.

vendor maps

Our vendor and supplier mapping project illustrates the biopharmaceutical industry's investment in our state economies and in the health of the patients we serve.

  • relationships 3,064 vendor relationships
  • spending $1,012,464,772 vendor spending
Click to view Impact in MD
MD WWFH Chatter
  • Today we remember all those lost to HIV/AIDS & celebrate the significant advances made due to research https://t.co/90947aTJZf #WorldAIDSDay
    9 days ago
  • Happy Thanksgiving from the WWFH team. We are thankful for our passionate partners dedicated to public health! Haveā€¦ https://t.co/GydYEkraNs
    17 days ago
  • 1/2 of covered Americans on plans that don't offer mental health or substance use coverage; but the state can fix it https://t.co/3pXT4cGlZc
    20 days ago
Partner Spotlight
Immune Deficiency Foundation

The Immune Deficiency Foundation (IDF), founded in 1980, is the national non-profit patient organization dedicated to improving the diagnosis, treatment and quality of life of persons with PI through advocacy, education and research. There are approximately 250,000 people who are diagnosed with PI in the U.S., and thousands more go undetected.

Learn More

Vendor Spotlight
Global Biohazard Technologies, Inc.

Global Biohazard Technologies, Inc. is a full-service biocontainment and biosafety consulting company staffed by biosafety professionals committed to providing state-of-the-art biosafety consultation to institutions and companies concerned with the design, construction, and operation of their biocontainment facilities.

Learn More

share this page